NTGN - Neon Therapeutics Inc
Previous close
3.07
0 0%
Share volume: 0
Last Updated: Tue 05 May 2020 06:00:00 AM CEST
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
$3.07
0.00
0.00%
Summary score
20%
Profitability
25%
Dept financing
7%
Liquidity
34%
Performance
15%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-27.92%
Return on assets
-21.26%
Return on sales
0%
Return on invested capital
-229.78%
Total debt ratio
15.4%
Debt ratio change over timeo
-1.03%
Current Ratio
9.49%
Quick Ratio
0%
Cash Position Ratio
7.25%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-40.85%
Return on assets
-29.07%
Return on sales
0%
Return on invested capital
-348.43%
Total debt ratio
26.13%
Debt ratio change over timeo
-1.06%
Current Ratio
5.25%
Quick Ratio
0%
Cash Position Ratio
4%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
-60.65%
Return on assets
-36.01%
Return on sales
0%
Return on invested capital
-377.81%
Total debt ratio
36.56%
Debt ratio change over time
-1.11%
Current Ratio
3%
Quick Ratio
0%
Cash Position Ratio
2.82%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-95.25%
Return on assets
-96.83%
Return on sales
0%
Return on invested capital
-101.63%
Total debt ratio
-102.83%
Debt ratio change over time
-1.03%
Current Ratio
-1.55%
Quick Ratio
0%
Cash Position Ratio
-1.58%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NTGN | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -27.92% | -40.03% | -11.51% | -12.25% |
| Return on assets | -21.26% | -20.27% | -9.11% | -9.49% |
| Return on sales | 0% | -5539.23% | 0% | -349.39% |
| Return on invested capital | -229.78% | 349.09% | -191.96% | -117.39% |
| Profitability | 25% | 25% | 50% | 0% |
| Total debt ratio | 15.4% | 125.77% | 25.3% | 26.21% |
| Debt ratio change over time | -1.03% | -0.06% | -1.13% | -1.45% |
| Dept financing | 3% | 50% | 5% | 5% |
| Current Ratio | 5.25% | 8.31% | 6.61% | 5.39% |
| Quick Ratio | 0% | 0% | 0% | 5.05% |
| Cash Position Ratio | 4% | 8.05% | 3.25% | 1.44% |
| Liquididy | 49% | 45% | 25% | 58% |
| Short-term ratios | NTGN | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -40.85% | -134.45% | -20.57% | -15.76% |
| Return on assets | -29.07% | -16.29% | -15.58% | -8.71% |
| Return on sales | 0% | 0% | 0% | -357.21% |
| Return on invested capital | -348.43% | 472.13% | 34.44% | -41.71% |
| Profitability | 25% | 25% | 2% | 50% |
| Total debt ratio | 26.13% | 73.06% | 29.07% | 45.86% |
| Debt ratio change over time | -1.06% | -0.87% | -1.78% | -2.24% |
| Dept financing | 9% | 50% | 10% | 16% |
| Current Ratio | 5.25% | 8.31% | 6.61% | 5.39% |
| Quick Ratio | 0% | 0% | 0% | 5.05% |
| Cash Position Ratio | 4% | 8.05% | 3.25% | 1.44% |
| Liquididy | 28% | 50% | 30% | 46% |